$100m Dementia Discovery Fund

The announcement will be made at the World Health Organisation's (WHO) First Ministerial Conference on Global Action Against Dementia by health secretary Jeremy Hunt.

The fund, which will be developed in the coming months, will be invested in by  pharmaceutical companies Biogen, GlaxoSmithKline, Johnson & Johnson and Lilly and Pfizer.

Prime Minister David Cameron said of the fund: "If we are to truly defeat this devastating disease, there must be a bold and determined global effort to invest in medical research. This fund is a major step forward in this effort. And it is thanks to the growing strength of our economy that the UK is able to lead the way – investing in pioneering research and drug development to tackle this condition once and for all."

Read More

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho